Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model

Clinical Rheumatology ◽

10.1007/s10067-008-1075-x ◽

2008 ◽

Vol 28 (3) ◽

pp. 333-337 ◽

Author(s):

Sang Tae Choi ◽

Ji Hye Kim ◽

Jae-Yeon Seok ◽

Yong-Beom Park ◽

Soo-Kon Lee

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Therapeutic Effect ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Collagen Induced Arthritis ◽

Endothelial Growth Factor

Download Full-text

Buyang huanwu decoction promotes angiogenesis via vascular endothelial growth factor receptor-2 activation through the PI3K/Akt pathway in a mouse model of intracerebral hemorrhage

BMC Complementary and Alternative Medicine ◽

10.1186/s12906-015-0605-8 ◽

2015 ◽

Vol 15 (1) ◽

Author(s):

Han-Jin Cui ◽

A-Li Yang ◽

Hua-Jun Zhou ◽

Cong Wang ◽

Jie-Kun Luo ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Intracerebral Hemorrhage ◽

Growth Factor Receptor ◽

Akt Pathway ◽

Vascular Endothelial ◽

Buyang Huanwu Decoction ◽

Endothelial Growth Factor

Download Full-text

A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis

Molecular Medicine Reports ◽

10.3892/mmr.2013.1500 ◽

2013 ◽

Vol 8 (2) ◽

pp. 434-438 ◽

Author(s):

HENG-XIU YAN ◽

YONG WANG ◽

XIAO-NONG YANG ◽

LI-XIN FU ◽

DONG-MEI TANG

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer

Carcinogenesis ◽

10.1093/carcin/bgl113 ◽

2006 ◽

Vol 27 (10) ◽

pp. 2133-2139 ◽

Author(s):

R.A. Goodlad

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Growth Factor Receptor ◽

Tumor Burden ◽

Intestinal Cancer ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis

Arthritis & Rheumatism ◽

10.1002/art.24764 ◽

2009 ◽

Vol 60 (9) ◽

pp. 2666-2676 ◽

Author(s):

Ruolin Guo ◽

Quan Zhou ◽

Steven T. Proulx ◽

Ronald Wood ◽

Rui-Cheng Ji ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Inflammatory Arthritis ◽

Growth Factor Receptor ◽

Lymphatic Drainage ◽

Vascular Endothelial ◽

Chronic Inflammatory Arthritis ◽

Endothelial Growth Factor

Download Full-text

Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization

Clinical and Experimental Ophthalmology ◽

10.1111/j.1442-9071.2012.02813.x ◽

2012 ◽

Vol 41 (1) ◽

pp. 63-72 ◽

Author(s):

Seungbum Kang ◽

Ki Cheol Park ◽

Keum‐Jin Yang ◽

Hyun‐Su Choi ◽

So‐Hee Kim ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Tyrosine Kinase ◽

Choroidal Neovascularization ◽

Receptor Tyrosine Kinase ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

1227 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (VEGFR2) ATTENUATES STEATOSIS AND INFLAMMATION IN A DIET-INDUCED MOUSE MODEL FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Journal of Hepatology ◽

10.1016/s0168-8278(12)61239-2 ◽

2012 ◽

Vol 56 ◽

pp. S486-S487

Author(s):

S. Coulon ◽

F. Heindryckx ◽

I. Colle ◽

C. Van Steenkiste ◽

L. Libbrecht ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Alcoholic Steatohepatitis ◽

Endothelial Growth Factor

Download Full-text

Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-0147 ◽

2008 ◽

Vol 14 (17) ◽

pp. 5447-5458 ◽

Author(s):

Tobias Martens ◽

Yvonne Laabs ◽

Hauke S. Günther ◽

Dirk Kemming ◽

Zhenping Zhu ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Mouse Model ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Nude Mouse Model ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text

A comparative study of gene vaccines encoding different extracellular domains of the vascular endothelial growth factor receptor 2 in the mouse model of colon adenocarcinoma CT-26

Cancer Biology & Therapy ◽

10.4161/cbt.7.4.5477 ◽

2008 ◽

Vol 7 (4) ◽

pp. 502-509 ◽

Author(s):

Jian Dong ◽

Jun Yang ◽

Ming Qing Chen ◽

Xi Cai Wang ◽

Zhi Ping Wu ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Mouse Model ◽

Comparative Study ◽

Growth Factor Receptor ◽

Colon Adenocarcinoma ◽

Vascular Endothelial ◽

Extracellular Domains ◽

Endothelial Growth Factor

Download Full-text

An Anti-Vascular Endothelial Growth Factor Receptor 2/Fetal Liver Kinase-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu+ Breast Tumors in a Mouse Model

The Journal of Immunology ◽

10.4049/jimmunol.0803742 ◽

2009 ◽

Vol 182 (9) ◽

pp. 5537-5546 ◽

Author(s):

Matthew M. Seavey ◽

Paulo C. Maciag ◽

Nada Al-Rawi ◽

Duane Sewell ◽

Yvonne Paterson

Keyword(s):

Vascular Endothelial Growth Factor ◽

Listeria Monocytogenes ◽

Growth Factor ◽

Mouse Model ◽

Fetal Liver ◽

Growth Factor Receptor ◽

Breast Tumors ◽

Vascular Endothelial ◽

Her 2 ◽

Endothelial Growth Factor

Download Full-text

Fortgeschrittenes medulläres Schilddrüsenkarzinom: Vandetanib verbessert das progressionsfreie Überleben

Onkologische Welt ◽

10.1055/s-0038-1631032 ◽

2012 ◽

Vol 03 (02) ◽

pp. 93-92

Author(s):

Alexander Kretzschmar

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Phase Iii ◽

Vascular Endothelial ◽

Medulläres Schilddrüsenkarzinom ◽

Epidermal Growth ◽

Endothelial Growth Factor

Vandetanib ist ein oraler Hemmer des RET-Kinase-, VEGF (Vascular Endothelial Growth Factor Receptor)- und EGFR (Epidermal Growth Factor Receptor)-Signalwegs. In einer zulassungsrelevanten, randomisierten, doppelblinden, placebokontrollierten Phase- III-Studie verlängerte der Tyrosinkinasehemmer das progressionsfreie Überleben (PFS) signifikant länger als Placebo.

Download Full-text